Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

October 22, 2019October 22, 2019

Voxelotor May Reduce Severity and Number of Leg Ulcers, Trial Analysis Suggests

News

Voxelotor can reduce the severity of existing leg ulcers and the incidence of new ones in people with sickle cell disease (SCD), new clinical trial results suggest. The findings ... Read more

September 24, 2019September 24, 2019

Emergency Department Less Likely to Provide Recommended Care for VOEs, Study Finds

News

Children with sickle cell disease (SCD) who arrive at an emergency department with vaso-occlusive episodes (VOEs) are more likely to have a longer delay before treatment, receive less narcotics ... Read more

August 15, 2019August 15, 2019

New Technology May Allow for Better Monitoring of Sickle Cell Disease

News

A new way to monitor blood cells that doesn’t require microscopic imaging or biochemical markers may allow for better management of sickle cell disease, a study suggests. The study, ... Read more

June 11, 2019June 11, 2019

GBT Awards $200K in ACCEL Grants to Improve SCD Healthcare Delivery

News

Global Blood Therapeutics (GBT) announced the five organizations that will receive more than $200,000 worth of grants through its new Access to Excellent Care for Sickle Cell Patients Pilot ... Read more